New research supports brain cell transplantation as a treatment for some neurological disorders. A team from McGill ...

Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a ...

In a mouse model of amyotrophic lateral sclerosis, the authors correlated neuronal TMEM106b fibrils with loss of nuclear TDP-43, a hallmark of the disease. Similarly, in a tauopathy mouse model, the ...

In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...

Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative ... in delaying onset of disease and mortality in an ALS mouse model. Passive immunization through intraventricular infusion ...

With its ability to improve neuron health, experimental drug NU-9 has already shown promise in reversing amyotrophic lateral ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

For example, while we know that getting a good workout in can benefit the nervous system by boosting our mood and helping us ...